https://www.selleckchem.com/products/cq211.html
n of patients at risk remains difficult. A multidimensional focus is probably needed to reduce risks.While a minority of patients with ulcerative colitis has primary sclerosing cholangitis (PSC), a significant proportion of patients with PSC have ulcerative colitis. The activity of PSC is usually not commensurate with the degree of concomitant colonic inflammation. Moreover, up to one-third of patients with a history of ulcerative colitis may paradoxically experience worsening of their colonic inflammation despite receiving immunosuppress
Like
Comment
Share
